GlassScriptPhysician profile
William J Cole
NPI 1316929771
$2,282.28
in general payments reported to CMS, 2019-2025
33 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $419 · 2021: $319 · 2022: $270 · 2023: $262 · 2024: $359 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,005.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $883.27 | 2019-2025 | Xtampza |
| Abbott Laboratories | $146.68 | 2024-2025 | Proclaim |
| Galderma Laboratories, L.P. | $124.96 | 2020 | |
| Almatica Pharma LLC | $116.37 | 2021-2023 | Gralise |
| Nevro Corp. | $110.04 | 2019-2024 | Senza |
| Abbvie INC. | $108.13 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $103.97 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $82.30 | 2025 | |
| Forte Bio-Pharma LLC | $68.65 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.40 | 2019 | |
| Avanos Medical | $42.38 | 2024 | Coolief* Cooled Radiofrequency, Standard Rf Disposables |
| Spr Therapeutics, INC | $29.36 | 2025 | Sprint Pns System |
| Assertio Therapeutics, INC. | $29.05 | 2019 | |
| Allergan, INC. | $28.06 | 2022 | |
| Boston Scientific Corporation | $27.18 | 2024 | Na |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $21.77 | 2025 | |
| Orthogenrx INC. | $21.47 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.42 | 2022 | |
| Globus Medical, INC. | $21.03 | 2025 | Senza |
| Pacira Therapeutics, INC. | $20.79 | 2020 | |
| Daiichi Sankyo INC. | $20.27 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.55 | 2023 | Exparel, Zilretta, Iovera |
| Sonex Health, INC. | $19.15 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.18 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.09 | 2022 | |
| Bioventus LLC | $16.57 | 2021 | |
| Biodelivery Sciences International, INC. | $16.30 | 2021 | |
| Ermi LLC | $16.07 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.08 | 2021 | |
| Azurity Pharmaceuticals, INC. | $14.84 | 2024 | Horizant |
| Depuy Synthes Sales INC. | $14.72 | 2019 | |
| Medtronic, INC. | $13.47 | 2021 | |
| Fidia Pharma USA INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.